231 related articles for article (PubMed ID: 28721605)
1. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.
Muehe AM; Theruvath AJ; Lai L; Aghighi M; Quon A; Holdsworth SJ; Wang J; Luna-Fineman S; Marina N; Advani R; Rosenberg J; Daldrup-Link HE
Mol Imaging Biol; 2018 Apr; 20(2):324-335. PubMed ID: 28721605
[TBL] [Abstract][Full Text] [Related]
2. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
3. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
4. Speeding up PET/MR for cancer staging of children and young adults.
Aghighi M; Pisani LJ; Sun Z; Klenk C; Madnawat H; Fineman SL; Advani R; Von Eyben R; Owen D; Quon A; Moseley M; Daldrup-Link HE
Eur Radiol; 2016 Dec; 26(12):4239-4248. PubMed ID: 27048532
[TBL] [Abstract][Full Text] [Related]
5. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
[TBL] [Abstract][Full Text] [Related]
6. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
7. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary nodule detection in oncological patients - Value of respiratory-triggered, periodically rotated overlapping parallel T2-weighted imaging evaluated with PET/CT-MR.
de Galiza Barbosa F; Geismar JH; Delso G; Messerli M; Huellner M; Stolzmann P; Veit-Haibach P
Eur J Radiol; 2018 Jan; 98():165-170. PubMed ID: 29279157
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
[TBL] [Abstract][Full Text] [Related]
11. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
[TBL] [Abstract][Full Text] [Related]
17. Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading.
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Beiderwellen K; Ruhlmann V; Umutlu L; Quick HH; Antoch G; Buchbender C
Eur J Radiol; 2015 Jul; 84(7):1285-92. PubMed ID: 25975895
[TBL] [Abstract][Full Text] [Related]
18. Impact of Computer-Aided CT and PET Analysis on Non-invasive T Staging in Patients with Lung Cancer and Atelectasis.
Flechsig P; Rastgoo R; Kratochwil C; Martin O; Holland-Letz T; Harms A; Kauczor HU; Haberkorn U; Giesel FL
Mol Imaging Biol; 2018 Dec; 20(6):1044-1052. PubMed ID: 29679299
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
20. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
